• Boustead Securities

Boustead Securities Client AngioSoma, Inc. Starts SOMA Nutraceuticals, Inc.’s Operations

HOUSTON, TEXAS – (Uptick Newswire, April 26, 2017) – AngioSoma, Inc., (OTC Pink: SOAN) recently filed its 10K for the period ending September 30, 2016 and its 10Q for the period ending December 31, 2016.  AngioSoma, Inc.’s management would like to update its shareholders on recent progress within its 2017 business plan, including starting operations at its SOMA Nutraceuticals, Inc. subsidiary and retaining Boustead Securities LLC.

Read the full article at:



6 Venture, Suite 395

Irvine, CA 92618 USA

Locate Us



  • White LinkedIn Icon
  • White Facebook Icon
For any general inquiries, please fill in the following contact form: